Home » Stocks » Aytu BioScience

Aytu BioScience, Inc. (AYTU)

Stock Price: $0.989 USD -0.031 (-3.05%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $0.990 +0.001 (0.11%) Oct 27, 7:47 PM

Stock Price Chart

Key Info

Market Cap 124.44M
Revenue (ttm) 27.63M
Net Income (ttm) -13.62M
Shares Out 125.84M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE 10.70
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $0.989
Previous Close $1.020
Change ($) -0.031
Change (%) -3.05%
Day's Open 1.020
Day's Range 0.973 - 1.020
Day's Volume 1,533,926
52-Week Range 0.335 - 2.990

More Stats

Market Cap 124.44M
Enterprise Value 89.29M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 125.84M
Float 109.69M
EPS (basic) -0.30
EPS (diluted) -0.30
FCF / Share -0.63
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 11.45M
Short Ratio 3.33
Short % of Float 10.44%
Beta 0.19
PE Ratio n/a
Forward PE 10.70
P/FCF Ratio n/a
PS Ratio 4.50
PB Ratio 1.31
Revenue 27.63M
Operating Income -21.13M
Net Income -13.62M
Free Cash Flow -28.37M
Net Cash 35.15M
Net Cash / Share 0.28
Gross Margin 72.67%
Operating Margin -76.47%
Profit Margin -49.30%
FCF Margin -102.68%
ROA -13.49%
ROE -26.68%
ROIC -2,360.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$2.62*
(164.94% upside)
Low
2.25
Current: $0.989
High
3.00
Target: 2.62
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014
Revenue27.637.323.663.222.560.260.06
Revenue Growth277.47%100%13.61%25.72%878.85%344.23%-
Gross Profit20.085.121.611.801.610.170.06
Operating Income-21.13-16.85-19.70-20.13-21.70-7.63-6.35
Net Income-13.62-27.13-10.19-22.51-28.18-7.72-5.58
Shares Outstanding45.197.790.670.47---
Earnings Per Share-0.30-3.48-15.31-48.30-6,474.00-4,028.00-3,840.15
Operating Cash Flow-28.37-13.83-15.94-13.83-10.66-6.63-5.50
Capital Expenditures--0.06-0.07-0.11-0.25--0.01
Free Cash Flow-28.37-13.89-16.02-13.94-10.91-6.63-5.51
Cash & Equivalents48.3311.297.110.889.107.362.64
Total Debt13.18---5.38-4.60
Net Cash / Debt35.1511.297.110.883.727.36-1.96
Assets15334.7221.0615.0024.3418.1912.02
Liabilities57.8227.637.6411.0014.262.576.65
Book Value95.027.0913.424.0010.0915.625.37
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Aytu BioScience, Inc.
Country United States
Employees 75
CEO Joshua R. Disbrow

Stock Information

Ticker Symbol AYTU
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AYTU

Description

Aytu BioScience, a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.